Engaging Community Pharmacists in Improving Treatment Outcomes for Patients with Opioid Use Disorder
September 24, 2024Today, the National Association of Boards of Pharmacy and the National Community Pharmacists Association will begin distributing a first-of-its-kind practice guideline to the nation’s 60,000...
Webinar
Webinar: State Policy Landscape to Address the Opioid and Overdose Crisis in 2024 (3/13)
February 27, 2024As drug overdose fatalities continue to rise, state policymakers are navigating changes on multiple fronts in substance use policy, such...
Webinar
Webinar: Federal Policy and Regulatory Opportunities to Address the Opioid and Overdose Crisis in 2024 (1/25)
January 04, 2024The past year brought about several major policy changes that aimed to better address the nation’s opioid and overdose crisis....
Webinar
Webinar: Strengthening the Opioid Use Disorder Workforce: Findings from a Groundbreaking Multi-State Survey of Peer Recovery Coaches (6/12/2023)
May 25, 2023As people with lived experience of addiction and recovery, peer recovery coaches (PRCs) are often the lynchpin to engaging people...
Webinar
Webinar: Impact of the End of the COVID-19 Public Health Emergency on Opioid Use Disorder Treatment (5/16/2023)
April 27, 2023The federal Public Health Emergency for COVID-19 (PHE) has transformed dramatically the landscape for opioid use disorder and other drug...
Webinar
Webinar: Expanding Access to Opioid Use Disorder Treatment During and After Incarceration (3/23/2023)
March 02, 2023At the end of January 2023, the Centers for Medicare and Medicaid Services approved California’s 1115 waiver amendment application to...
Webinar
Webinar: Beyond X-ing the X-Waiver (3/9/2023)
February 15, 2023At the end of 2022, President Biden signed into law the removal of the X-Waiver requirement to prescribe buprenorphine to...